HER2-positive metastatic breast cancer

May 15 ASCO Quick Takes: After-hours pop for Iovance, MacroGenics; plus Takeda, Amgen, Forty Seven
May 15 ASCO Quick Takes: After-hours pop for Iovance, MacroGenics; plus Takeda, Amgen, Forty Seven
BioCentury
Iovance
LN-145
cervical cancer
Takeda
TAK-788
non-small cell lung cancer
Amgen
AMG-510
Macrogenics
margetuximab
HER2-positive metastatic breast cancer
Forty Seven
Flag link:
FDA approves Celltrion's Herceptin biosimilar
FDA approves Celltrion's Herceptin biosimilar
BioCentury
FDA
Herceptin
biosimilars
Celltrion
HER2-positive metastatic breast cancer
Flag link:
Chinese Biotech Bio-Thera Solutions Initiates Ph III Trial of HER2 ADC in Metastatic Breast Cancer
Chinese Biotech Bio-Thera Solutions Initiates Ph III Trial of HER2 ADC in Metastatic Breast Cancer
CP Wire
Bio-Thera Solutions
HER2-positive metastatic breast cancer
BAT8001
China
Flag link:
Chinese Biotech Bio-Thera Solutions Initiates Ph III Trial of HER2 ADC in Metastatic Breast Cancer
Bio-Thera Solutions
HER2-positive metastatic breast cancer
BAT8001
Flag link:
Seattle Genetics Announces Results of Two Ph II Trials of Tucatinib in HER2- Positive Metastatic Breast Cancer
Seattle Genetics Announces Results of Two Ph II Trials of Tucatinib in HER2- Positive Metastatic Breast Cancer
CP Wire
Seattle Genetics
tucatinib
orphan drugs
clinical trials
HER2-positive metastatic breast cancer
breast cancer
Flag link:
Seattle Genetics Announces Results of Two Ph II Trials of Tucatinib in HER2- Positive Metastatic Breast Cancer
Seattle Genetics
tucatinib
breast cancer
HER2-positive metastatic breast cancer
Flag link:
Pfizer's Herceptin biosimilar succeeds in key breast cancer study
Pfizer's Herceptin biosimilar succeeds in key breast cancer study
Yahoo/Reuters
Pfizer
biosimilars
Herceptin
PF-05280014
HER2-positive metastatic breast cancer
Flag link:
Oncothyreon Breast Cancer Drug Exits ASCO '15 With Good Buzz
Oncothyreon Breast Cancer Drug Exits ASCO '15 With Good Buzz
TheStreet.com
Oncothyreon
breast cancer
ASCO
ONT-380
HER2-positive metastatic breast cancer
Flag link:
Puma Biotechnology Announces Presentation of Positive PB272 Phase II Data at the 2014 ASCO Annual Meeting
Puma Biotechnology Announces Presentation of Positive PB272 Phase II Data at the 2014 ASCO Annual Meeting
Yahoo/BusinessWire
Puma Biotechnology
PB272
breast cancer
HER2-positive metastatic breast cancer
Flag link:
NICE rejects Roche's hot new breast cancer drug Kadcyla, then invites negotiations
NICE rejects Roche's hot new breast cancer drug Kadcyla, then invites negotiations
Fierce Pharma
breast cancer
Roche
NICE
Kadcyla
HER2-positive metastatic breast cancer
Flag link: